Facebook Linkedin RSS Twitter Youtube
Home 2024

Novo Nordisk

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus
Bioprocessing

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment
Artificial Intelligence

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

Top 10 Best Selling Drugs
A-Lists

Top 10 Best Selling Drugs

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration
Industry News

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration

StockWatch: Amgen Throws Its Weight Behind Obesity Drug
Drug Discovery

StockWatch: Amgen Throws Its Weight Behind Obesity Drug

Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline
Drug Discovery

Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B
Bioprocessing

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B

GTC 2024: Nvidia’s Quantum Expansion Runs through the Cloud
Artificial Intelligence

GTC 2024: Nvidia’s Quantum Expansion Runs through the Cloud

89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field
Drug Discovery

89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field

StockWatch: Madrigal Shares Soar as FDA Nears Historic MASH Decision
Cancer

StockWatch: Madrigal Shares Soar as FDA Nears Historic MASH Decision

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.